Skip to main content

Table 1 Epidemiological characteristics of pulmonary tuberculosis patients notified in Shanghai, China, in the first half of each of 2017 and 2018*

From: Effect of the Xpert MTB/RIF on the detection of pulmonary tuberculosis cases and rifampicin resistance in Shanghai, China

CharacteristicsTotal
n (%)
(n = 6047)
PTB patients of 2017
n (%)
(n = 2938)
PTB patients of 2018
n (%)
(n = 3109)
p-value
Sex   0.912
 Female1910 (31.6)930 (31.7)980 (31.5) 
 Male4137 (68.4)2008 (68.3)2129 (68.5) 
Age   0.198
 15–291887 (31.2)904 (30.8)983 (31.6) 
 30–441190 (19.7)578 (19.7)612 (19.7) 
 45–591171 (19.4)601 (20.5)570 (18.3) 
  > =601799 (29.8)855 (29.1)944 (30.4) 
Hospital   0.928
 County-level1901 (31.4)922 (31.4)979 (31.5) 
 Referral4146 (68.6)2016 (68.6)2130 (68.5) 
Local resident   0.829
 No2781 (46.0)1347 (45.8)1434 (46.1) 
 Yes3266 (54.0)1591 (54.2)1675 (53.9) 
TB case   0.208
 New5608 (92.7)2712 (92.3)2896 (93.1) 
 Previously treated439 (7.3)226 (7.7)213 (6.9) 
Bacteriological confirmation   < 0.001
 Yes3290 (54.4)1461 (49.7)1829 (58.8) 
DST coverage   < 0.001
 Yes2573 (42.6)1066 (36.3)1507 (48.5) 
RR-TB detection   0.004
 Yes156 (2.6)58 (2.0)98 (3.2) 
  1. PTB pulmonary tuberculosis
  2. Xpert Xpert MTB/RIF
  3. MTB Mycobacteria of tuberculosis
  4. RIF Rifampicin
  5. RR-TB Rifampicin-resistant tuberculosis
  6. DST Drug susceptibility test
  7. *Xpert was implemented in 2018